Medtronic Expands Hugo Robotic System with CE-Marked LigaSure Technology

Medtronic has received CE mark approval in Europe for integrating its LigaSure vessel-sealing technology with the Hugo robotic-assisted surgery system. This milestone boosts Hugo’s capabilities in gynecologic, general, and urologic surgeries across Europe. Although Hugo is not yet available in the U.S., Medtronic anticipates its entry into the American market by April 2026, starting with urology. LigaSure, known for sealing blood vessels in approximately two seconds while minimizing thermal spread, enhances surgical precision and safety. Its adoption is helping Medtronic gain traction in the advanced energy market. Hugo, which initially received CE mark in 2021, is now operational in over 30 countries. Medtronic announced the LigaSure approval during the Society of Robotic Surgeons Annual Meeting in Strasbourg, where it also planned to present new gynecologic data and conduct a live telesurgery demonstration. The integration of LigaSure strengthens Medtronic’s position against competitors like Intuitive Surgical in the expanding robotic surgery space.

23-07-2025